Results 291 to 300 of about 382,920 (355)

Shoulder Pain in a 33-Year-Old Male Found to Have Multiple Myeloma. [PDF]

Cureus
Eusanio E, Altaf R, Hassanein H, Carlan S.   +3 more
europepmc   +1 more source

Cost‐effective analysis of teclistamab and daratumumab versus ciltacabtagene autoleucel in relapsed multiple myeloma

British Journal of Haematology, EarlyView.
Sohaib Irfan, M. Abdullah Jamil, Muhammad Bilal Abid   +2 more
wiley   +1 more source

Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib study

Blood Cancer Journal
Fan Yang, Rui Liu, Zhonghua Fu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Alex H. Chang, Haifeng Wu, Shilin Gan, Chen Chen, Xiaoyan Ke, Kai Hu   +12 more
doaj   +1 more source

Whole-body Dual-source Photon-counting CT in Multiple Myeloma-The Value of Virtual Monoenergetic Imaging for Lesion Vitality Assessment. [PDF]

Invest Radiol
Heidemeier A, Huflage H, Rasche L, Kortuem KM, Waldschmidt JM, Einsele H, Schlötelburg W, Bley TA, Grunz JP.   +8 more
europepmc   +1 more source

Real‐world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high‐risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry

British Journal of Haematology, EarlyView.
Kenneth J. C. Lim, Elham Ashrafi, Cameron Wellard, Elizabeth M. Moore, Betty Gration, Bradley Augustson, Peter Mollee, Jennifer Zhang, Nicole Wong Doo, Karen Dun, Rachel Cooke, Sabine Ringkowski, Adam Bryant, Georgia McCaughan, Erica Wood, Zoe McQuilten, P. Joy Ho, Hang Quach, Andrew Spencer   +18 more
wiley   +1 more source

Safety profile of chimeric antigen receptor T‐cell therapy in relapsed/refractory multiple myeloma: A systematic review and meta‐analysis of proportions from clinical trials

British Journal of Haematology, EarlyView.
Charalampos Filippatos, Ioannis Ntanasis‐Stathopoulos, Areti Voulomenou, Panagiotis Malandrakis, Efstathios Kastritis, Maria Gavriatopoulou, Meletios‐Athanasios Dimopoulos, Evangelos Terpos   +7 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Multiple myeloma

Nature Reviews Disease Primers, 2017
Multiple myeloma is a malignancy of terminally differentiated plasma cells, and patients typically present with bone marrow infiltration of clonal plasma cells and monoclonal protein in the serum and/or urine. The diagnosis of multiple myeloma is made when clear end-organ damage attributable to the plasma cell proliferative disorder or when findings ...
Shaji Kumar, S Vincent Rajkumar, Robert A Kyle   +2 more
exaly   +7 more sources

Diagnosis and Management of Multiple Myeloma: A Review.

Journal of the American Medical Association (JAMA), 2022
Importance Multiple myeloma is a hematologic malignancy characterized by presence of abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth causing destructive bone lesions, kidney injury, anemia, and hypercalcemia ...
A. Cowan, D. Green, M. Kwok, Sarah S. Lee, D. Coffey, L. Holmberg, S. Tuazon, A. Gopal, E. Libby   +8 more
semanticscholar   +1 more source